Pranlukast hemihydrate is a chemical compound that acts as an active pharmaceutical ingredient. It is a bisamide derivative containing a tetrazole-substituted chromenone core and a phenylbutoxybenzamide moiety, and it is supplied in a hemihydrate form for pharmaceutical manufacturing purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 150821-03-7
Pranlukast
pharmaceutical raw material
Tirofiban hydrochloride hydrate
pharmaceutical raw material
Cetirizine Polyethylene Glycol (PEG) Ester
pharmaceutical raw material
Betamethasone sodium phosphate
pharmaceutical raw material
Moxifloxacin
pharmaceutical raw material
bis(N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide);hydrate
MSXTUBJFNBZPGC-UHFFFAOYSA-N
C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5.C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5.O